Genelux Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.06	9.42	0.4	4.5	11.35
Short-Term Investments	15.57	13.77	0	0	0
Cash & Cash Equivalents	19.63	23.19	0.4	4.5	11.35
Cash Growth	89.85%	5741.56%	-91.17%	-60.40%	-
Other Current Assets	1.58	1.01	1.5	1.33	0.13
Total Current Assets	21.2	24.2	1.89	5.82	11.48
Property, Plant & Equipment	3.38	3.6	1.98	2.21	2.45
Other Long-Term Assets	0.09	0.09	1.66	0.09	0.08
Total Long-Term Assets	3.47	3.69	3.64	2.3	2.53
Total Assets	24.68	27.89	5.53	8.13	14.01
Accounts Payable	5.31	3.78	6.78	4.46	3.71
Deferred Revenue	0	0	0.17	4.5	0
Current Debt	0.58	0.65	16.4	6.16	3.61
Other Current Liabilities	1.91	2.12	8.28	7.37	7.18
Total Current Liabilities	7.81	6.55	31.63	22.48	14.49
Long-Term Debt	1.79	1.87	9.69	18.75	22.17
Total Long-Term Liabilities	1.79	1.87	9.69	18.75	22.17
Total Liabilities	9.59	8.42	41.31	41.24	36.66
Total Debt	2.37	2.52	26.09	24.91	25.78
Debt Growth	-22.19%	-90.34%	4.73%	-3.36%	-
Retained Earnings	-229.37	-221.52	-189.78	-184.58	-168.23
Comprehensive Income	-0.01	0.01	0	0	0
Shareholders' Equity	15.08	19.47	-35.78	-33.11	-22.66
Net Cash / Debt	17.26	20.67	-25.69	-20.41	-14.43
Net Cash / Debt Growth	136.68%	-	-	-	-
Net Cash Per Share	0.64	0.85	-2.82	-2.26	-0.58
Working Capital	13.4	17.65	-29.73	-16.66	-3.02
Book Value Per Share	0.56	0.80	-3.92	-3.67	-0.90

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).